Partners

Beneficiaries

Helmholz Munich (coordinator), Germany (HMGU)

AstraZeneca AB, Sweden (AstraZeneca)

Bayer Aktiengesellschaft, Germany (Bayer)

Pfizer Pharma GmbH, Germany (since 01/12/2022, Pfizer)

Janssen Pharmaceutica NV , Belgium (Janssen)

Enamine Limited Liability Company, Ukraine (Enamine)

Aalto University, Finland (AALTO)

Freie Universität Berlin, Germany (FUB)

Katholieke Universiteit Leuven, Belgium (KUL)

Johannes Kepler Universität Linz, Austria (JKU)

Scuola Universitaria Professionale della Svizzera Italiana, Switzerland (SUPSI)

TU Dortmund, Germany (01/2021 - 19/05/2022)

Johannes Gutenberg-Universität Mainz  (since 01/03/2022) (JGU)

Universiteit Leiden, Netherlands (ULEI)

Université du Luxembourg, Luxembourg (ULUX)

University of Vienna, Austria (UNIVIE)

Universitat Pompeu Fabra, Spain (UPF)

Vancouver Prostate Center, University of British Columbia, Canada (own contribution) (VPC)

Associated Partners

Technical University of Munich, Germany (TUM)

University of Southern Switzerland (USI)

Ascenion GmbH, Germany (Ascenion)

Novartis Institutes for Biomedical Research, Switzerland (Novartis)

University of North Carolina at Chapel Hill, USA (UNC)

La Trobe University, Australia (LTU)

Bar-Ilan University, Israel (BIU)

Guangzhou Regenerative Medicine and Health-Guangdong Laboratory, Centre of Chemistry and Chemical Biology, China (GRMH-GDL)

Instituto di Ricerche Farmacologiche "Mario Negri", Italy (IRFMN)

Max Planck Institute of Molecular Physiology, Germany (MPI)

Beijing University of Chemical Technology, China (BUCT)

Chelonia SA, Switzerland (Chelonia)